EP1102578A4 - A new analgesic, anti-inflammatory and wound healing agent - Google Patents
A new analgesic, anti-inflammatory and wound healing agentInfo
- Publication number
- EP1102578A4 EP1102578A4 EP99942002A EP99942002A EP1102578A4 EP 1102578 A4 EP1102578 A4 EP 1102578A4 EP 99942002 A EP99942002 A EP 99942002A EP 99942002 A EP99942002 A EP 99942002A EP 1102578 A4 EP1102578 A4 EP 1102578A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inflammatory
- wound healing
- healing agent
- new analgesic
- analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9509098P | 1998-08-03 | 1998-08-03 | |
US95090P | 1998-08-03 | ||
PCT/US1999/017642 WO2000007566A1 (en) | 1998-08-03 | 1999-08-03 | A new analgesic, anti-inflammatory and wound healing agent |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1102578A1 EP1102578A1 (en) | 2001-05-30 |
EP1102578A4 true EP1102578A4 (en) | 2005-05-18 |
Family
ID=22249490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99942002A Withdrawn EP1102578A4 (en) | 1998-08-03 | 1999-08-03 | A new analgesic, anti-inflammatory and wound healing agent |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1102578A4 (en) |
CN (1) | CN1311665A (en) |
AU (1) | AU5547099A (en) |
CA (1) | CA2348637A1 (en) |
MX (1) | MXPA01000973A (en) |
WO (1) | WO2000007566A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000040172A1 (en) * | 1999-01-05 | 2000-07-13 | East Carolina University | Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
MXPA06014026A (en) * | 2004-07-02 | 2007-02-08 | Warner Lambert Co | Compositions and methods for treating pathological infections. |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
CN101417121B (en) * | 2007-10-27 | 2011-09-28 | 董昌金 | Medicine capable of curing skin burning and freezing injury |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
JP6362268B2 (en) * | 2012-11-05 | 2018-07-25 | 塩野義製薬株式会社 | Method for evaluating drug efficacy and screening method for EL activity inhibitory substance having therapeutic or preventive effect on diseases associated with EL activity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0382019A1 (en) * | 1989-01-31 | 1990-08-16 | BIORESEARCH S.p.A. | Use of 5-methyltetrahydrofolic acid, of 5-formyl-tetrahydrofolic acid and of their pharmaceutically acceptable salts for the preparation of controlled release pharmaceutical compositions suitable for the use in the therapy of depressive disturbances, and pharmaceutical compositions thus prepared |
US5118505A (en) * | 1988-01-28 | 1992-06-02 | Koeltringer Peter | Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury |
WO1998019690A1 (en) * | 1996-11-06 | 1998-05-14 | Bristol-Myers Squibb Company | Method for treating alzheimer's disease |
EP0898965A2 (en) * | 1997-06-13 | 1999-03-03 | EPROVA Aktiengesellschaft | Use of tetrahydrofolates for modulating the homocysteine level |
WO2000040172A1 (en) * | 1999-01-05 | 2000-07-13 | East Carolina University | Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5419996A (en) * | 1977-07-08 | 1979-02-15 | Wellcome Found | Pyrimido*4*55c*pyridazines |
CH673459A5 (en) * | 1987-05-15 | 1990-03-15 | Eprova Ag | |
US5534513A (en) * | 1991-09-05 | 1996-07-09 | Taiho Pharmaceutical Company, Ltd. | Antitumor potentiator and antitumor composition |
US5438075A (en) * | 1993-03-30 | 1995-08-01 | Skubitz; Keith M. | Oral glutamine to reduce stomatitis |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
PT877563E (en) * | 1996-01-31 | 2004-08-31 | Univ South Alabama | FOOD AND VITAMINIC PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES |
-
1999
- 1999-08-03 CN CN99809298A patent/CN1311665A/en active Pending
- 1999-08-03 WO PCT/US1999/017642 patent/WO2000007566A1/en not_active Application Discontinuation
- 1999-08-03 EP EP99942002A patent/EP1102578A4/en not_active Withdrawn
- 1999-08-03 CA CA002348637A patent/CA2348637A1/en not_active Abandoned
- 1999-08-03 AU AU55470/99A patent/AU5547099A/en not_active Abandoned
- 1999-08-03 MX MXPA01000973A patent/MXPA01000973A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118505A (en) * | 1988-01-28 | 1992-06-02 | Koeltringer Peter | Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury |
EP0382019A1 (en) * | 1989-01-31 | 1990-08-16 | BIORESEARCH S.p.A. | Use of 5-methyltetrahydrofolic acid, of 5-formyl-tetrahydrofolic acid and of their pharmaceutically acceptable salts for the preparation of controlled release pharmaceutical compositions suitable for the use in the therapy of depressive disturbances, and pharmaceutical compositions thus prepared |
WO1998019690A1 (en) * | 1996-11-06 | 1998-05-14 | Bristol-Myers Squibb Company | Method for treating alzheimer's disease |
EP0898965A2 (en) * | 1997-06-13 | 1999-03-03 | EPROVA Aktiengesellschaft | Use of tetrahydrofolates for modulating the homocysteine level |
WO2000040172A1 (en) * | 1999-01-05 | 2000-07-13 | East Carolina University | Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
Non-Patent Citations (5)
Title |
---|
CASTRO ALONSO F J ET AL: "Treatment of ocular toxoplasmosis", FARMACIA CLINICA, vol. 15, no. 2, March 1998 (1998-03-01), pages 119 - 124, XP009045489, ISSN: 0212-6583 * |
DAVIES ET AL: "FACILITATORY AND DIRECT EXCITATORY EFFECTS OF FOLATE AND FOLINATE ON SINGLE NEURONES OF CAT CEREBRAL CORTEX", BIOCHEMICAL PHARMACOLOGY, PERGAMON, OXFORD, GB, vol. 13, no. 22, 1 July 1973 (1973-07-01), pages 1667 - 1668, XP001078712, ISSN: 0006-2952 * |
KELLY G S: "Folates: supplemental forms and therapeutic applications.", ALTERNATIVE MEDICINE REVIEW : A JOURNAL OF CLINICAL THERAPEUTIC. JUN 1998, vol. 3, no. 3, June 1998 (1998-06-01), pages 208 - 220, XP009045488, ISSN: 1089-5159 * |
KEPKA L ET AL: "Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure.", LEUKEMIA & LYMPHOMA. MAR 1998, vol. 29, no. 1-2, March 1998 (1998-03-01), pages 205 - 209, XP009045482, ISSN: 1042-8194 * |
See also references of WO0007566A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2348637A1 (en) | 2000-02-17 |
CN1311665A (en) | 2001-09-05 |
WO2000007566A1 (en) | 2000-02-17 |
EP1102578A1 (en) | 2001-05-30 |
MXPA01000973A (en) | 2002-06-04 |
AU5547099A (en) | 2000-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000274774A1 (en) | Wound site management and wound closure device | |
EP1073401A4 (en) | Topical anesthetic formulation | |
TWI316062B (en) | Anti-inflammatory compounds and uses thereof | |
HUP9904094A3 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent | |
HK1040939A1 (en) | A compound for tissue repair and the application thereof | |
AU7859800A (en) | Topical nasal treatment | |
SI1014993T1 (en) | New use for budesonide and formoterol | |
GB2357286B (en) | Shaped wound dressings | |
AU758325C (en) | Imidazole compounds and medicinal use thereof | |
AU5929499A (en) | A wound treatment composition and a wound dressing containing it | |
EP1102578A4 (en) | A new analgesic, anti-inflammatory and wound healing agent | |
AU2187699A (en) | Diterpene derivatives and anti-inflammatory analgesic agents comprising the same | |
AU5615999A (en) | A medical active water, manufacture and use thereof | |
AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
EP1051267A4 (en) | Extended length rotary bending and forming devices and methods for manufacture thereof | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
GB9608145D0 (en) | Wound healing | |
AU7559200A (en) | Hypertriglyceridemia remedies and antiobestics | |
GB2347087B (en) | Tape and tape dispenser | |
AU3035497A (en) | Device for reducing the length, and optionally the width, of a cot | |
AU2001239631A1 (en) | A new oligomer compound and a use thereof | |
AU1028000A (en) | Medicament utilization and combination | |
GB9814555D0 (en) | Wound healing | |
AU2001267827A1 (en) | Anti-inflammatory and analgesic agents | |
AU3852800A (en) | A construction and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010131 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EPIGENESIS PHARMACEUTICALS, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050406 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 29/00 B Ipc: 7A 61P 25/00 B Ipc: 7A 61P 23/00 B Ipc: 7A 61P 13/12 B Ipc: 7A 61P 9/00 B Ipc: 7A 61P 3/00 B Ipc: 7A 61K 45/06 B Ipc: 7A 61K 31/519 A |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050301 |